Pharma Value

Pharma

Value

To be able to find the right path for the introduction of a medicine in Italy, it is necessary to explore and translate the map of the regulatory environment, identifying and analysing the expectations and reports of decision-makers.

We assist those who turn to us in understanding and obtaining a fair price and reimbursement for a medicine. Finding a common ground, by appropriately mediating between Company profit, patient needs and the limited resources of the National Health Service, is a victory for all interest groups involved.

Through the years, we have learnt that the reality of things is more complex than whatever had been planned.

Even when everything is well-prepared and strategies corresponding to the value of the medicine, in accordance with the regulatory objectives of the agencies, and accommodating to drug governance guidelines, are proposed, the pathway to the authorisation of a medicine may well progress differently than expected. Not to mention any external variables that could slow down, if not hinder, the access of a medicine to the market.

Integrated skills are needed to help with navigation

Though quite detailed, the map we have provided cannot define the complexity of the terrain. Our experience comes to the aid when it is not clear.

Team Pharma Value

Easter 2021 - our best wishes

2 April 2021

Il #TeamPharmaValue vi fa tantissimi auguri qualsiasi cosa festeggiate! Con questa animazione abbiamo voluto raccontare la nostra visione per la Pasqua 2021. ...

Notes

1st OsMed Report on Parallel Import (IP) and Export of Medicines for Human Use by AIFA

31 March 2021

I° Rapporto OsMed sull’importazione parallela (IP) ed esportazione dei medicinali per uso umano di AIFA Puoi rivederlo qui https://lnkd.in/dRgRGUV Nella presentazione di ...

Notes

New application form for listing of medicines under Law 648/96

30 March 2021

AIFA ha pubblicato un nuovo modulo per la richiesta di inserimento di medicinali nell’elenco ai sensi della legge 648/96; si evincono alcune ...

Notes

Scientific Committee on Post-Market Surveillance of COVID-19 Vaccines (CSV-Covid19)

19 March 2021

L’AIFA, il 14 dicembre 2020, ha costituito un comitato scientifico per la sorveglianza post-marketing dei vaccini COVID-19 (CSV-Covid19). Il CSV-Covid19 rimarrà in ...

Notes

Coronavirus: new set-up for the Scientific Technical Committee. Reduction in the number of members and new professionalism

17 March 2021

Con il Decreto del Capo Dipartimento della Protezione civile n. 371 del 5 febbraio 2020, è stato istituito il Comitato Tecnico Scientifico ...

Notes

Working Group for the Coordination of the National Antimicrobial Resistance Strategy

12 March 2021

Tornano gli appunti di Pharma Value con l’aggiornamento della composizione del Gruppo di lavoro per il coordinamento della strategia nazionale di contrasto ...